Dolutegravir-Rilpivirine, Dual Antiretroviral Therapy for the Treatment of HIV-1 Infection.

CONCLUSIONS: This dual therapy combination of DTG-RPV provides maintenance of virological suppression as a switch strategy with few drug interactions and positive effects on lipids and renal and bone health. PMID: 30758229 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30758229?dopt=Abstract

Source: The Annals of Pharmacotherapy - February 13, 2019 Category: Drugs & Pharmacology Authors: Hester EK, Astle K Tags: Ann Pharmacother Source Type: research